Table 1.
Histopathology diagnosis from cervical quadrants with or without visible lesions.a
| Histopathology diagnosis | Random biopsy from cervical quadrants without visible lesions | Targeted biopsy from cervical quadrants with visible lesions | |||||
|---|---|---|---|---|---|---|---|
| Total b | Women with no cervical quadrants with visible lesions | Women with one or more cervical quadrants with visible lesion | Total b | Women with all cervical quadrants occupied by visible lesions | Women with one or more cervical quadrants without visible lesion | ||
| Benign | 113 (52.8) | 77 (58.3) | 36 (43.9) | 41 (30.2) | 11 (20.4) | 30 (36.6) | |
| CIN1 | 84 (39.3) | 47 (35.6) | 37 (45.1) | 57 (41.9) | 23 (42.6) | 34 (41.5) | |
| CIN2 | 10 (4.7) | 4 (3.0) | 6 (7.3) | 17 (12.5) | 9 (16.7) | 8 (9.8) | |
| CIN3 | 4 (1.9) | 2 (1.5) | 2 (2.4) | 19 (14.0) | 10 (18.5) | 9 (11.0) | |
| Cancer | 3 (1.4) | 2 (1.5) | 1 (1.2) | 2 (1.5) | 1 (1.9) | 1 (1.2) | |
Abbreviation: CIN, cervical intraepithelial neoplasia.
a
Values are given as number (percentage).
b
Distribution of biopsy results from cervical quadrants with visible lesions is significantly more advanced than biopsy results from quadrants without visible lesions (P<0.001 by χ2 test).